nilutamide has been researched along with dehydroepiandrosterone sulfate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huot, RI; Shain, SA | 1 |
BĂ©langer, A; Dupont, A; Labrie, F | 1 |
Boccardo, F; Decensi, A; Marroni, P; Padovani, P; Pensa, F; Torrisi, R | 1 |
1 trial(s) available for nilutamide and dehydroepiandrosterone sulfate
Article | Year |
---|---|
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Androgen Antagonists; Androgens; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Triptorelin Pamoate | 1994 |
2 other study(ies) available for nilutamide and dehydroepiandrosterone sulfate
Article | Year |
---|---|
Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
Topics: Androgen Antagonists; Androgens; Animals; Cell Division; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Rats; Receptors, Androgen; Testosterone | 1986 |
Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Androgen Antagonists; Androgens; Buserelin; Castration; Combined Modality Therapy; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Imidazoles; Imidazolidines; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1984 |